Literature DB >> 1904424

T cell receptor-independent cell-mediated cytotoxicity by nude mouse lymphokine-activated killer cells.

T Nishimura1, Y Togashi, N Wakamiya, Y Hashimoto, H Yagita, K Okumura, S Habu.   

Abstract

Lymphokine-activated killer (LAK) cells, which can lyse a variety of tumor cells, can be induced from both normal and athymic nude mouse spleen cells by culture with high doses of recombinant interleukin 2 (rIL-2). LAK cells generated from nude mouse spleen cells (Nude-LAK cells) express just Thy 1.2 antigen, but not CD4 and CD8 antigens. Nude-LAK cells express neither T3 molecule, T cell receptor (TCR) alpha beta nor TCR gamma delta on their cell surface. The lack of TCR expression on Nude-LAK cells was confirmed by the results of northern blot analysis. LAK cells generated from normal mouse spleen cells (Nor-LAK) express TCR alpha, beta transcripts, while Nude-LAK cells express only sterile TCR beta transcript, but not TCR alpha transcript. TCR gamma delta transcripts were scarcely detected in both Nor-LAK cells and Nude-LAK cells. Thus, it is strongly suggested that Nude-LAK cells can recognize and lyse tumor cells by TCR-independent mechanisms. Monoclonal antibody against lymphocyte function-associated antigen (LFA-1) molecule can block the cytotoxicity of Nude-LAK cells, indicating an important role of such accessory molecules in Nude-LAK cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904424      PMCID: PMC5918446          DOI: 10.1111/j.1349-7006.1991.tb01869.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


recombinant interleukin 2 lymphokine‐activated killer cells LAK cells generated from T cells LAK cells generated from NK cells lymphocyte function‐associated antigen‐1 T cell receptor LAK cells generated from nude mouse spleen cells LAK cells generated from normal mouse spleen cells
  45 in total

1.  A monoclonal antibody against altered LFA-1 induces proliferation and lymphokine release of cloned T cells.

Authors:  H Pircher; P Groscurth; S Baumhütter; M Aguet; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

2.  A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes.

Authors:  I Bank; R A DePinho; M B Brenner; J Cassimeris; F W Alt; L Chess
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

3.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

4.  Lymphokine-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicity.

Authors:  T Nishimura; H Yagi; H Yagita; Y Uchiyama; Y Hashimoto
Journal:  Cell Immunol       Date:  1985-08       Impact factor: 4.868

5.  Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.

Authors:  S Ferrini; S Miescher; M R Zocchi; V von Fliedner; A Moretta
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

6.  The lymphocyte function-associated antigen (LFA)-1 and CD2/LFA-3 pathways of antigen-independent human T cell adhesion.

Authors:  S Shaw; G E Luce
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

7.  Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.

Authors:  T Kalland; H Belfrage; P Bhiladvala; G Hedlund
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes.

Authors:  T Nishimura; H Yagi; Y Uchiyama; Y Hashimoto
Journal:  Cell Immunol       Date:  1986-06       Impact factor: 4.868

9.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Authors:  U Landegren; U Ramstedt; I Axberg; M Ullberg; M Jondal; H Wigzell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Lymphokine-activated killer cells. Analysis of progenitors and effectors.

Authors:  J R Ortaldo; A Mason; R Overton
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  2 in total

1.  Induction of lymphokine-activated killer cells from nude mouse spleen cells by interleukin-4.

Authors:  I S Tunru; H Suzuki; M Kobayashi
Journal:  Experientia       Date:  1993-01-15

2.  Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.

Authors:  I Fichtner; R Reszka; S R Goan; H Naundorf
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.